Literature DB >> 200705

Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice.

J Yoon, T Onodera, A L Notkins.   

Abstract

The diabetogenic capacity of the M-variant of encephalomyocarditis (EMC) virus was markedly diminished after passage in mouse kidney cell cultures. One passage in mice fully restored this capacity. Virus harvested after five passages in either susceptible (SWR/J) or resistant (C57BL/6J) strains of mice was capable of producing diabetes in susceptible SWR/J mice but not in resistant C57BL/6J mice. Resistance was not overcome by inoculating mice with high concentrations of virus. Immunofluorescence studies showed that islets from strains of mice (i.e. CBA, AKR, C57BL/6J, A/J) that did not develop diabetes after infection with EMC virus, nonetheless, contained virus antigens. The percentage of cells in the islets containing virus antigens varied from 3-6% in CBA to 13-5% in A/J. In contrast 38% of the islet cells in susceptible SWR/J mice contained virus antigens. It is concluded that both the genetic background of the host and the passage history of the virus influence the development of diabetes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200705     DOI: 10.1099/0022-1317-37-2-225

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation.

Authors:  J W Yoon; A K Wong; Y S Bae; H M Eun
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice.

Authors:  M T Barger; J E Craighead
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Encephalomyocarditis virus leader is phosphorylated by CK2 and syk as a requirement for subsequent phosphorylation of cellular nucleoporins.

Authors:  Holly A Basta; Valjean R Bacot-Davis; Jessica J Ciomperlik; Ann C Palmenberg
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

4.  Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus.

Authors:  H S Jun; Y Kang; A L Notkins; J W Yoon
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Virus-induced diabetes mellitus: mengovirus infects pancreatic beta cells in strains of mice resistant to the diabetogenic effect of encephalomyocarditis virus.

Authors:  J W Yoon; T Morishima; P R McClintock; M Austin; A L Notkins
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood.

Authors:  L Blom; L Nyström; G Dahlquist
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

7.  Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats.

Authors:  G R Grotendorst; G R Martin; D Pencev; J Sodek; A K Harvey
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

8.  Effect of steroid hormones on virus-induced diabetes mellitus.

Authors:  D J Giron; R R Patterson
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection.

Authors:  Zachary R Shaheen; Aaron Naatz; John A Corbett
Journal:  J Immunol       Date:  2015-09-25       Impact factor: 5.422

10.  Picornavirus infection leading to immunosuppression.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2014-05-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.